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2001. The survey focused on a subset of applied articles
in English, after excluding methodological, environmen-
tal or veterinarian studies, and those not reporting cost
data. Finally, articles employing MCS for purposes other
than conducting PSA were excluded. Descriptive analyses
were used to evaluate their methods.
RESULTS: Of the 319 articles identiﬁed, 39 met the 
inclusion/exclusion criteria. Of these 39 studies, 64%
were published after 1998. PSA was commonly used to
reﬂect uncertainty regarding probabilities or costs, but
less commonly for utilities. When applicable, the distrib-
ution type was speciﬁed for 42%, 56%, and 64% of
utility, cost, and probability parameters, respectively.
Sixty-one percent of studies used uniform, triangular or
normal distributions. Justiﬁcation for the distribution
type was inconsistently reported. Only 8% of studies
assumed some correlation between parameters or pre-
sented absolute worst- or best-case scenarios, which the-
oretically bound all possible simulation results. Over
70% of studies used acceptability thresholds or curves for
reporting cost-effectiveness results.
CONCLUSIONS: Our survey indicates that the use of
PSA is increasingly popular. However, how these methods
have been applied has rarely been sufﬁciently transpar-
ent. PSA is relatively new in health economics and studies
employing this technique should provide transparent
descriptions of their methods. This will improve the
acceptability and usefulness of PSA, while providing 
guidance to analysts wishing to use this powerful 
methodology.
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In response to European regulators’ concern about the
methodology followed to translate and achieve cultural
adaptation of Health-related Quality of Life (HRQL)
instruments (i.e. the process of adapting a measure from
a source to a target language), the ERIQA Group has inte-
grated the development of regulators-targeted guidance
documents for cross-cultural adaptation into their pro-
gramme. The ﬁrst step in collaboration with Mapi
Research Institute has been to investigate current 
guidelines.
OBJECTIVES: To identify and analyse the methods used
for cultural adaptation of HRQL instruments.
METHODS: Medline and Embase were searched using
the keywords “quality of life”, “questionnaires”, “health
status indicators” which were matched with “translating”
and “cross-cultural comparison”. Papers published
between January 1966 and April 2001 were taken into
consideration. 173 references were identiﬁed. Mapi
Research Institute’s database was searched using “trans-
lation issues”, “cross-cultural comparison”, and “cross-
cultural research”, with 236 references as a result. 409
abstracts were reviewed. Inclusion criteria were: 1) the
paper should propose guidelines/recommendations or 2)
it should review and analyse methods.
RESULTS: 32 papers met with the inclusion criteria. 14
sets of guidelines were identiﬁed. A lack of consensus
emerged about: a) the terminology qualifying the process
of adapting a HRQL instrument from source to target
language, and b) the scope covered by this terminology.
Similarities included multiple forward translations, 
reconciliation sessions, and some form of back-
translations. Differences appeared in the importance
given to back-translation, forms of panel testing, and
translators’ recruitment criteria. Few articles compared
methodologies.
CONCLUSION: This review shows disparity in deﬁni-
tions and methods. Further investigations may be needed
in order to explore empirical evidence of the methods’
effectiveness, and propose recommendations for 
regulators.
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OBJECTIVES: Evaluate the claim that Utility Theory
(UT) is normative.
METHODS: Logical analysis of UT and normative
injunctions. The positive/normative distinction is between
“is” and “ought.” Positive statements describe how
things are; normative injunctions (e.g., “First, cause no
harm”) request that we act in certain ways. The norma-
tive interpretation of UT suggests that we should act so
as to maximize our utility.
RESULTS: The normative interpretation of UT leaves 
the individual with a decision to make: “Should I act so
as to maximize my utility?” If the individual applies UT
as a decision procedure to answer this question, then an
afﬁrmative answer to the question is being assumed and
not proved. Alternatively, the individual could attempt to
justify the use of UT by appealing to a more general deci-
sion procedure. But if the more general decision proce-
dure can decide this question, then why use UT at all?
The more general decision procedure could be used in the
place of UT to decide everyday questions. But, then, the
more general decision procedure requires justiﬁcation. To
justify its use, we must appeal to an even more general
decision procedure. So, we embark upon an inﬁnite
regress when trying to justify UT by appealing to more
general decision procedures. The logical problem with the
normative view of UT does not carry over to medical deci-
sion making in general, where an external criterion is used
as an indicator for a particular characteristic. Vis a vis
medical decision making, the logical problem with the
